(Q51971591)

English

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

scientific article published in January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

0 references

circulatory system

1 reference

based on heuristic

inferred from title

author name string

M E Liechti

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

F X Vollenweider

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

14

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

269-274

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

The psychological and physiological effects of MDMA on normal volunteers.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Alcohol and drug use in UK university students.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400313

21 January 2018

Identifiers

10.1177/026988110001400313

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11106307

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51971591&oldid=1609184827"